Diffuse Large B-cell Lymphoma (DLBCL)

Diffuse Large B Cell  lymphoma (DLBCL) is a group of blood cancers that changes certain blood cells in your body called B-cell lymphocytes (B-cells). It usually starts when B-cells in  your lymph nodes (sometimes called glands) and your lymphatic system become cancerous. These are all part of your body’s immune system which fight infection and disease. There are several different types of DLBCL which includes:

  • Primary mediastinal B-cell lymphoma (PMBCL)
  • T-cell/histiocyte rich B-cell lymphoma (T/HRBCL)
  • EBV-positive DLBCL not otherwise specified ((NOS)
  • ALK-positive large B-cell lymphoma
  • Intravascular large B-cell lymphoma
  • Primary central nervous system lymphoma (PCNSL)
  • Cutaneous (skin) B-cell lymphoma
Download DLBCL Fact Sheet
Speak to a Lymphoma Care Nurse
Patient & Carer Education
Support Groups

About DLBCL

Learn what DLBCL is, what causes it, and how it develops at a cellular level.

Other Resources

Diffuse Large B-Cell Lymphoma (DLBCL)

Understanding Non-Hodgkin Lymphoma (NHL)

Support Groups

Online Support Groups
Monday 7th of September 2026
2:30pm AEST - 4:00pm AEST
In Person Support Groups
Monday 7th of September 2026
10:30am AEST - 12:00pm AEST 355 Botany Rd, Zetland 2017
Online Support Groups
Thursday 17th of September 2026
10:00am AEST - 11:30am AEST

Patient Stories

Hailey’s Journey with Diffuse Large B Cell Lymphoma (DLBCL)

Ty’s Story: DLBCL

Tahli’s Story: Non Hodgkin Large B Cell Lymphoma

This educational resource hub was proudly sponsored by

Contact Lymphoma Australia Today!

Please note:
Lymphoma Australia staff are only able to reply to emails sent in English language.

Useful Definitions

  • Refractory: This means the lymphoma does not get better with treatment. The treatment didn’t work as hoped.
  • Relapsed: This means the lymphoma came back after being gone for a while after treatment.
  • 2nd line treatment: This is the second treatment you get if the first one didn’t work (refractory) or if the lymphoma comes back (relapse).
  • 3rd line treatment: This is the third treatment you get if the second one didn’t work or the lymphoma comes back again.
  • Approved: Available in Australia and listed by the Therapeutics Goods Administration (TGA).
  • Funded: Costs are covered for Australian citizens. This means if you have a Medicare card, you shouldn’t have to pay for the treatment.[WO7]

You need healthy T-cells to make CAR T-cells. For this reason, CAR T-cell therapy cannot be used if you have a T-cell lymphoma – yet.

For more information on CAR T-cells and T-cell lymphoma click here. 

Special Note: Although your T-cells are removed from your blood for CAR T-cell therapy, most of our T-cells live outside of our blood – in our lymph nodes, thymus, spleen and other organs.